Create accountLogin

Recent searches

No recent searches

Search options

Only available when logged in.
med-mastodon.com is one of the many independent Mastodon servers you can use to participate in the fediverse.
Medical community on Mastodon

Administered by:

Server stats:

393
active users

med-mastodon.com: AboutProfiles directoryPrivacy policy

Mastodon: AboutGet the appKeyboard shortcutsView source codev4.3.8

Filip Janku

Relatively hopeful data from MARIO-3 (eganelisib, atezolizumab and nab-paclitaxel in 1L mTNBC. It has to be viewed cautiously as comparisons are made to historical population of IM130 but for now PI3K-gamma inhibition appears to be resurrected

businesswire.com/news/home/202

www.businesswire.comInfinity Pharmaceuticals Provides MARIO-3 Update in Patients with Front Line Metastatic Triple Negative Breast Cancer Suggesting Potential Long-Term Patient Benefit of EganelisibInfinity Pharmaceuticals, Inc. (NASDAQ: INFI) (“Infinity” or the “Company”), a clinical-stage biotechnology company developing eganelisib, a first-in-
Nov 21, 2022, 09:36 PM·Public·Web
0boosts·0favorites
ExploreLive feeds
About